A key resource for heavyweights in the life sciences sector, Carpmaels & Ransford LLP is best known for litigating major drug, chemicals, tech, and other patent disputes across the UK courts and the UPC. The group is also well-versed in IP-rich transactions, EPO oppositions, and patent prosecution strategy. Jointly led by disputes lawyer Ian Kirby, Hugh Goodfellow, and transactions-focused Jake Marshall, the team includes life sciences specialist Jennifer Antcliff, who acts for clients in patent and SPC litigation, and Simon Llewellyn, who handles cross-border disputes in the healthcare sector. Agathe Michel-de Cazotte‘s expertise includes coordinating parallel litigation and UPC-related work, and Craig Lumb comes recommended for life sciences disputes.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Sector knowledge
Testimonials
Collated independently by Legal 500 research team.
‘Excellent team leading the UK firms in UPC work. Fantastic synergy between the prosecution experts and the litigators.’
‘Ian Kirby leads the team brilliantly. Always innovative. Jenny Antcliff is up and coming, as is Simon Llewellyn. Some brilliant new recruits.’
Key clients
- Sanofi
- Johnson & Johnson
Work highlights
Secured a UPC revocation decision of the Central Division UPC for Sanofi and Regeneron.
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Craig Lumb
Practice head
Ian Kirby; Hugh Goodfellow; Jake Marshall
Other key lawyers
Jennifer Antcliff; Simon Llewellyn; Agathe Michel-de Cazotte; Craig Lumb; Daniel Wise; Paul Kaufman; David Wilson